These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33940641)

  • 1. Prenatal Low-Dose Aspirin Use Associated with Reduced Incidence of Postpartum Hypertension among Women with Preeclampsia.
    Christenson E; Stout MJ; Williams D; Verma AK; Davila-Roman VG; Lindley KJ
    Am J Perinatol; 2023 Mar; 40(4):394-399. PubMed ID: 33940641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients.
    Lopes Perdigao J; Chinthala S; Mueller A; Minhas R; Ramadan H; Nasim R; Naseem H; Young D; Shahul S; Chan SL; Yeo KJ; Rana S
    Hypertension; 2019 Apr; 73(4):868-877. PubMed ID: 30798660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Placental sFLT1 (Soluble fms-Like Tyrosine Kinase Receptor-1) Drives the Antiangiogenic Profile of Maternal Serum Preceding Preeclampsia but Not Fetal Growth Restriction.
    Gaccioli F; Sovio U; Gong S; Cook E; Charnock-Jones DS; Smith GCS
    Hypertension; 2023 Feb; 80(2):325-334. PubMed ID: 35866422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension.
    Heimberger S; Mueller A; Ratnaparkhi R; Perdigao JL; Rana S
    Pregnancy Hypertens; 2020 Apr; 20():124-130. PubMed ID: 32299059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
    Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
    Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preeclampsia: Guidelines for clinical practice from the French College of Obstetricians and Gynecologists].
    Sentilhes L; Schmitz T; Arthuis C; Barjat T; Berveiller P; Camilleri C; Froeliger A; Garabedian C; Guerby P; Korb D; Lecarpentier E; Mattuizzi A; Sibiude J; Sénat MV; Tsatsaris V
    Gynecol Obstet Fertil Senol; 2024 Jan; 52(1):3-44. PubMed ID: 37891152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary placental growth factor and risk of preeclampsia.
    Levine RJ; Thadhani R; Qian C; Lam C; Lim KH; Yu KF; Blink AL; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    JAMA; 2005 Jan; 293(1):77-85. PubMed ID: 15632339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period.
    Petrozella L; Mahendroo M; Timmons B; Roberts S; McIntire D; Alexander JM
    Am J Obstet Gynecol; 2012 Aug; 207(2):140.e20-6. PubMed ID: 22840727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic markers during preeclampsia: Are they associated with hypertension 1 year postpartum?
    Neuman RI; Figaroa AMJ; Nieboer D; Saleh L; Verdonk K; Danser AHJ; Duvekot HJJ; van den Meiracker AH; Roeters van Lennep J; Visser W
    Pregnancy Hypertens; 2021 Mar; 23():116-122. PubMed ID: 33321329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
    Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
    Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased postpartum exercise capacity after a diagnosis of pre-eclampsia: Implications for CVD risk prediction.
    Lindley KJ; Barker C; Mahmoud Z; Raghuraman N; Lenzen P; Meyers R; Osmundson S; Huang S; Shah RV; Davila-Roman VG
    Am Heart J; 2024 Sep; 275():192-199. PubMed ID: 38944263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.
    Powers RW; Jeyabalan A; Clifton RG; Van Dorsten P; Hauth JC; Klebanoff MA; Lindheimer MD; Sibai B; Landon M; Miodovnik M;
    PLoS One; 2010 Oct; 5(10):e13263. PubMed ID: 20948996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
    Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
    Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.